Real-World Data Back Immunotherapy Boost for Early-Stage Triple-Negative Breast Cancer
A new meta-analysis of five observational studies finds that adding pembrolizumab to neoadjuvant chemotherapy in early-stage triple-negative breast cancer appears ...
